The first experience of stem cell labeling in Iran using 111In- Oxine [Persian]

Authors

  • Ali Gholamrezanezhad Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Ardeshir Ghavamzadeh Hematology, Oncology and BMT Research center, Tehran University of Medical Sciences, Tehran, Iran
  • Davood Beiki Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Jalil Majd Ardekani Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  • Kamran Alimoghadam Hematology, Oncology and BMT Research center, Tehran University of Medical Sciences, Tehran, Iran
  • Kianoush Ansari Gilani Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Maryam Bashtar Hematology, Oncology and BMT Research center, Tehran University of Medical Sciences, Tehran, Iran
  • Mehdi Mohammadnezhad Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Mohammad Bagheri Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Mohsen Saghari Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Reza Malekzadeh Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Sahar Mirpour Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract:

  Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111In- oxine for the first time in our country. The aim of this study was to investigate the possibility of stem cell labeling in Iran. In addition the researchers assessed the cell viability, specific activity and labeling efficiency after labeling. Methods:  After culturing mesenchymal stem cells (MSCs), for radio-labeling, the sample (which contained 1×106MSCs) were mixed, and suspended with 50 µCi 111In-oxine, and then incubated for 20 min at the room temperature. The cells were then washed with normal saline twice to remove the free 111In. Results:  The labeling efficiency, specific activity and cell viability was 70.6%, 31.70 µCi/106 and 100%, respectively. Conclusion: It seems that, this method is practical and easily applicable with acceptable efficiency and specific activity in our laboratory settings using pharmaceutical produced in Iran.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

the first experience of stem cell labeling in iran using 111in- oxine [persian]

introduction: the field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. stem cell therapy seems to be a new treatment option for some diseases. so, tracking the distribution of stem cells is crucial to their therapeutic use. based on this fact we labeled human mesenchymal stem cells (mscs) with 111in- oxine for the first time in our coun...

full text

Plerixafor in the Treatment of Stem Cell Mobilization Failure; First Experience in Iran

High-dose chemotherapy and autologous stem cell transplantation (SCT) have become an effective care for many patients with hematological malignancies. Harvesting the stem cells is one the most important parts of SCT. The two most commonly used mobilization regimens are the use of granulocyte colony-stimulating factor (G-CSF) or G-CSF plus chemotherapy. However, about 10-30% of patients are unab...

full text

Plerixafor in the Treatment of Stem Cell Mobilization Failure; First Experience in Iran

High-dose chemotherapy and autologous stem cell transplantation (SCT) have become an effective care for many patients with hematological malignancies. Harvesting the stem cells is one the most important parts of SCT. The two most commonly used mobilization regimens are the use of granulocyte colony-stimulating factor (G-CSF) or G-CSF plus chemotherapy. However, about 10-30% of patients are unab...

full text

the impact of e-readiness on ec success in public sector in iran the impact of e-readiness on ec success in public sector in iran

acknowledge the importance of e-commerce to their countries and to survival of their businesses and in creating and encouraging an atmosphere for the wide adoption and success of e-commerce in the long term. the investment for implementing e-commerce in the public sector is one of the areas which is focused in government‘s action plan for cross-disciplinary it development and e-readiness in go...

plerixafor in the treatment of stem cell mobilization failure; first experience in iran

high-dose chemotherapy and autologous stem cell transplantation (sct) have become an effective care for many patients with hematological malignancies. harvesting the stem cells is one the most important parts of sct. the two most commonly used mobilization regimens are the use of granulocyte colony-stimulating factor (g-csf) or g-csf plus chemotherapy. however, about 10-30% of patients are unab...

full text

the norms of localization in translating persian multimodal texts: the case of videogame demos

abstract هنجارهای بومی سازی در ترجمه متون چندوجهی فارسی:مورد دموهای بازیهای کامپیوتری چکیده اهداف عمده مطالعه حاضر به سه دسته تقسیم میشوند: 1) بررسی مشکلات احتمالی ترجمه دموهای (فیلمهای) بازیهای کامپیوتری،2) تعیین هنجارهای بومی سازی در ترجمه دموهای (فیلمهای) بازیهای کامپیوتری و 3) تعیین ایدئولوژیهایی که این هنجارها در جامعه نشان میدهند. به این منظور، ابتدا، مجموعه ای ازدموهای (فیلمهای) ب...

15 صفحه اول

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 15  issue 2

pages  25- 27

publication date 2007-10-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023